← All stocks

BeOne Medicines Ltd.

ONC Mostly scheduled

CIK 0001651308 #603 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$13.52M

$106.40K on a plan · $13.37M straight out of an exercise

Sold at will

$46.97K

1 of 10 sales

Net

−$13.52M

−$46.97K against sales at will

By person

18 insiders · 10 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Wang Xiaodong

Director

—

$13.37M (8) scheduled

−$13.37M

4,588,163

$1.61B

−10.9%

Wu Xiaobin

President and COO

—

$106.40K (1) scheduled

−$106.40K

1,308,161

$459.50M

+74.4%

Ball Titus B.

Principal Accounting Officer

—

$46.97K (1)

−$46.97K

97,929

$34.40M

+159.0%

HHLR ADVISORS, LTD. entity

10% owner

—

125,045,741

$43.92B

−12.5%

BAKER BROS. ADVISORS LP entity

Director

—

8,229,961

$2.89B

−17.1%

OYLER JOHN

Chief Executive Officer

—

5,697,649

$2.00B

—

Wang Lai

President, Global Head of R&D

—

1,710,085

$600.67M

+96.8%

Rosenberg Aaron

Chief Financial Officer

—

397,891

$139.76M

+306.6%

Lee Chan Henry

SVP, General Counsel

—

346,554

$121.73M

+161.1%

HOOPER ANTHONY C

Director

—

83,720

$29.41M

+55.7%

Dugan Margaret

Director

—

73,164

$25.70M

+68.5%

Riva Alessandro

Director

—

73,164

$25.70M

+68.5%

Sanders Corazon (Corsee) D.

Director

—

57,226

$20.10M

+23.2%

BRANDICOURT OLIVIER

Director

—

46,306

$16.27M

+183.4%

Sharp Shalini

Director

—

38,116

$13.39M

—

Yi Qingqing

Director

—

27,326

$9.60M

−40.8%

Sawyers Charles Lazelle

Director

—

18,984

$6.67M

+474,500%

Mooney Elizabeth Fisher

Director

—

18,980

$6.67M

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

BeOne Medicines Ltd.

By person

Individual transactions

What was left out